Johnson & Johnson Proposes $5.5 Billion Settlement for Talc Lawsuits

Johnson & Johnson has proposed a $5.5 billion settlement to resolve long-standing legal battles concerning claims that its talc-based products, including baby powder, caused cancer. The offer is part of a broader corporate strategy to ringfence its liabilities and move past thousands of lawsuits that have plagued the company for years. If accepted, the settlement would represent one of the largest corporate resolutions of its kind, though several claimant groups have already signaled they may hold out for a higher payout.

The settlement news comes as the healthcare giant attempts to transition its brand image toward newer pharmaceutical and medical device innovations. Legal analysts suggest the $5.5 billion figure is an attempt to provide certainty to shareholders who have grown weary of the talc-related litigation's impact on J&J's stock price. However, the proposal still requires court approval and the consent of a significant majority of plaintiffs to take full effect.